Paxam or Rivotril
MIMS Abbreviated Prescribing Information
Clonazepam
Section: 3(g) Anticonvulsants - Central Nervous System
Product Images: Paxam 0.5 mg, Paxam 2 mg
Use in pregnancy: B3*
Permitted in sport
Use: Benzodiazepine. Partial, generalised epilepsy in adults; most types of epilepsy in children esp absence, myoclonic seizures and tonic-clonic fits
Contraindications: Known benzodiazepine hypersensitivity; COAD with incipient respiratory failure; drug, alcohol, CNS depressant dependency; severe hepatic impairment
Precautions: Abrupt withdrawal; spinal, cerebellar ataxia; sleep apnoea; brain damage; acute narrow angle glaucoma; high dose; use > 4 wks (monitor LFTs, FBC); myasthenia gravis; hypotension sensitive conditions; respiratory, hepatic, renal impairment; depression, psychosis; acute alcohol intoxication; addiction prone; galactose intolerance, Lapp lactase deficiency, glucose/ galactose malabsorption (should not use); porphyria; elderly, debility; pregnancy, lactation (must not use); infants, small children
Adverse Reactions: CNS disturbance incl drowsiness, somnolence, impaired memory, amnesia, dizziness; incr fall risk; respiratory depression; salivary, bronchial hypersecretion (esp children); tolerance; dependence; incr frequency, severity of grand mal seizures; behaviour problems; fatigue; muscle weakness; ataxia; vertigo; paradoxical reaction (eg agitation, nervousness, hostility, anxiety, sleep disturbance, nightmares, vivid dreams, rage, stimulation, excitement); hypotension (rare); alopecia (rare); others, see full PI
Interactions: See Contra; CNS depressants eg anticonvulsants, Li, sedatives, hypnotics, barbiturates, antidepressants, antipsychotics, narcotics, anaesthetics, skeletal muscle relaxants, antihistamines; disulfiram; cimetidine; anticholinergics; respiratory depressants
Paxam (Tablets) Rx (S4) CMI
This product may cause drowsiness
Clonazepam; lactose; peach (0.5 mg), white (2 mg); cross scored; gluten free
Dose: May be taken with or without food. Individualise dose. Initially. Admin in 2 divided doses. Adults: 1 mg/day. Children, 2-5 yrs: 0.5 mg/day; 6-12 yrs: 0.75 mg/day. Maintenance. Admin in 3-4 divided doses. Adults: 4-8 mg/day; max 20 mg/day. Children, 2-5 yrs: 1.5-3 mg/day; 6-12 yrs: 3-6 mg/day. Elderly, hepatic impairment: may reduce dose
Pack 0.5 mg [100] : $21.99
Pack 0.5 mg [100] (G) : Authority - PBS/RPBS
[Approved indication(s) for authority] Continuing supply for palliative care patients for the prevention of epilepsy.
No applications for repeats will be authorised.
PBS: $13.31
Pack 0.5 mg [100] (G) : Authority - PBS/RPBS (Rp 3)
[Approved indication(s) for authority] Initial supply (for up to 4 months) for palliative care patients for the prevention of epilepsy;
Continuing supply for palliative care patients for the prevention of epilepsy, where consultation... [more...]
PBS: $13.31
Pack 0.5 mg [100] x 2 (G) : Authority - PBS/RPBS (Rp 2)
[Approved indication(s) for authority] Neurologically proven epilepsy. CAUTION: Abuse of clonazepam has been reported. Refer to the current product information.
PBS: $20.20
Pack 2 mg [100] : $34.97
Pack 2 mg [100] (G) : Authority - PBS/RPBS
[Approved indication(s) for authority] Continuing supply for palliative care patients for the prevention of epilepsy.
No applications for repeats will be authorised.
PBS: $19.38
Pack 2 mg [100] (G) : Authority - PBS/RPBS (Rp 3)
[Approved indication(s) for authority] Initial supply (for up to 4 months) for palliative care patients for the prevention of epilepsy;
Continuing supply for palliative care patients for the prevention of epilepsy, where consultation... [more...]
PBS: $19.38
Pack 2 mg [100] x 2 (G) : Authority - PBS/RPBS (Rp 2)
[Approved indication(s) for authority] Neurologically proven epilepsy. CAUTION: Abuse of clonazepam has been reported. Refer to the current product information.
PBS: $32.34